' '
Deutsch | English    

Research Database PMU-SQQUID

[Percutaneous administration of recombinant human bone morphogenetic protein-7 (rhBMP-7) after callus distraction. Two case reports].
Högel, F; Militz, M; Bühren, V; Augat, P; Wagner, F;
UNFALLCHIRURG. 2011; 114(2): 16-71.
Case Reports

PMU-Authors

Augat Peter
Bühren Volker
Högel Florian

Abstract

Two cases of increased bone density after callus distraction are described following percutaneous administration of 3.5 mg recombinant bone morphogenetic protein-7 (rhBMP-7). Both patients underwent segmental resection and segmental transport for osteomyelitis of the long bones (femur and tibia) but no callus maturation occurred. After percutaneous administration of rhBMP-7 the callus density increased in both cases.


Useful keywords (using NLM MeSH Indexing)

Administration, Topical

Adult

Bone Morphogenetic Protein 7/administration*

dosage*

Bony Callus/drug effects*

Fracture Healing/drug effects*

Humans

Intercellular Signaling Peptides and Proteins/administration*

dosage

Male

Osteitis/complications

Osteitis/drug therapy*

Osteitis/surgery*

Osteogenesis, Distraction*

Treatment Outcome

Young Adult


Find related publications in this database (Keywords)

Osteitis
Segment transport
Callus distraction
Callus thickness